Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Subscribe

Sci. Signal., 4 October 2011
Vol. 4, Issue 193, p. ra65
[DOI: 10.1126/scisignal.2002282]

RESEARCH ARTICLES

Editor's Summary

Networking Wnt into Neurodegeneration
Wnt signaling, which is crucial to brain development, has also been implicated in neurodegenerative diseases. Noting that Wnt activates various signaling pathways, which may involve numerous effectors, Wexler et al. performed a genome-wide analysis of the response of cultured human neural progenitor cells to Wnt1. Over the course of 3 days, they observed an oscillatory pattern of changes in the abundance of gene transcripts, including genes associated with neurodegenerative diseases, such as Alzheimer’s disease, Parkinson’s disease, and frontotemporal dementia (FTD). Having used computational analyses to identify a potential link between Wnt signaling and progranulin, deficiency of which is associated with FTD, the authors defined a reciprocal relationship between the two. Wnt1 signaling led to a decrease in progranulin abundance, whereas progranulin knockdown increased Wnt1 mRNA. Moreover, Wnt expression was increased in cortical tissue from people with an inherited form of FTD associated with haploinsufficiency of the gene encoding progranulin. Thus, their data are consistent with a role for Wnt signaling in FTD and possibly other neurodegenerative diseases.

Citation: E. M. Wexler, E. Rosen, D. Lu, G. E. Osborn, E. Martin, H. Raybould, D. H. Geschwind, Genome-Wide Analysis of a Wnt1-Regulated Transcriptional Network Implicates Neurodegenerative Pathways. Sci. Signal. 4, ra65 (2011).

Read the Full Text


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Progranulin Deficiency Promotes Post-Ischemic Blood-Brain Barrier Disruption.
K. Jackman, T. Kahles, D. Lane, L. Garcia-Bonilla, T. Abe, C. Capone, K. Hochrainer, H. Voss, P. Zhou, A. Ding, et al. (2013)
J. Neurosci. 33, 19579-19589
   Abstract »    Full Text »    PDF »
Blood RNA profiling in a large cohort of multiple sclerosis patients and healthy controls.
D. Nickles, H. P. Chen, M. M. Li, P. Khankhanian, L. Madireddy, S. J. Caillier, A. Santaniello, B. A. C. Cree, D. Pelletier, S. L. Hauser, et al. (2013)
Hum. Mol. Genet. 22, 4194-4205
   Abstract »    Full Text »    PDF »
Dynamic temporal requirement of Wnt1 in midbrain dopamine neuron development.
J. Yang, A. Brown, D. Ellisor, E. Paul, N. Hagan, and M. Zervas (2013)
Development 140, 1342-1352
   Abstract »    Full Text »    PDF »
Wnt signaling in bone formation and its therapeutic potential for bone diseases.
J. H. Kim, X. Liu, J. Wang, X. Chen, H. Zhang, S. H. Kim, J. Cui, R. Li, W. Zhang, Y. Kong, et al. (2013)
Therapeutic Advances in Musculoskeletal Diseases 5, 13-31
   Abstract »    PDF »
RBFOX1 regulates both splicing and transcriptional networks in human neuronal development.
B. L. Fogel, E. Wexler, A. Wahnich, T. Friedrich, C. Vijayendran, F. Gao, N. Parikshak, G. Konopka, and D. H. Geschwind (2012)
Hum. Mol. Genet. 21, 4171-4186
   Abstract »    Full Text »    PDF »

To Advertise     Find Products


Science Signaling. ISSN 1937-9145 (online), 1945-0877 (print). Pre-2008: Science's STKE. ISSN 1525-8882